Wells Fargo Maintains Overweight on Gilead Sciences, Raises Price Target to $145

Benzinga · 10/31/2025 21:12
Wells Fargo analyst Mohit Bansal maintains Gilead Sciences (NASDAQ:GILD) with a Overweight and raises the price target from $140 to $145.